Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and anti-inflammatory markers in type 2 diabetes
NCT01040819Phase 4Completed
- Sponsor
- Baylor College of Medicine
- Start
- Feb 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Baylor College of Medicine. Started Feb 2010; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01040819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01040819.